Error: Could not add to watchlist. X

Enzon Pharmaceuticals Inc

+ Watchlist
ENZN:US
NASDAQ CM
1.21
USD
0.06
4.72%
As of 20:10:00 ET on 07/03/2015.
Open
1.26
Day Range
1.21 - 1.26
Volume
565,885
Previous Close
1.27
52Wk Range
0.78 - 1.88
1 Yr Return
17.68%
Current P/E Ratio (TTM)
1.95
Earnings per Share (USD) (TTM)
0.62
Market Cap (m USD)
53.461
Shares Outstanding (m)
44.182
Price/Sales (TTM)
1.95
Dividend Indicated Gross Yield
41.32%
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company has developed several products, including PEG-INTRON. Enzon's product-focused strategy includes a drug development program that leverages its PEG modification and single-chain antibody (SCA) technologies.
ADDRESS
20 Kingsbridge Road
Piscataway, NJ 08854
United States
PHONE
1-732-980-4500
  • George W Hebard III
    COO/Secretary
  • Richard L Feinstein
    VP:Finance/Principal Financial Ofcr
Show More